Stock Market Update
27-May-26 11:05 ET
Boston Scientific plummets on guidance cut
Dow +300.09
at 50761.77,
Nasdaq -63.49
at 26613.69,
S&P -4.04
at 7515.08
[BRIEFING.COM] The major averages are little changed from previous values.
Boston Scientific (BSX 51.74, -5.90, -10.24%) is the worst-performing S&P 500 component after the company lowered its FY26 organic growth guidance to 6.5-8.0% and lowered its Q2 organic growth to 5-7%, both well below prior expectations.
The broader health care sector (+0.7%) remains one of the better-performing S&P 500 sectors, supported by gains across the majority of its components.
